Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,636
Closed -$4.13M 59
2025
Q1
$4.13M Sell
9,636
-1,634
-14% -$794K 1.14% 33
2024
Q4
$5.47M Buy
11,270
+519
+5% +$271K 1.47% 31
2024
Q3
$5.44M Buy
10,751
+5,289
+97% +$2.84M 1.28% 36
2024
Q2
$3.25M Sell
5,462
-712
-12% -$403K 0.82% 43
2024
Q1
$3.53M Sell
6,174
-52
-0.8% -$28.6K 0.87% 46
2023
Q4
$3.21M Sell
6,226
-1,120
-15% -$573K 0.89% 53
2023
Q3
$3.37M Sell
7,346
-178
-2% -$79.7K 1.01% 52
2023
Q2
$3.28M Sell
7,524
-81
-1% -$32.6K 0.93% 57
2023
Q1
$2.94M Buy
7,605
+263
+4% +$94K 0.91% 61
2022
Q4
$2.34M Buy
7,342
+782
+12% +$245K 0.87% 60
2022
Q3
$2M Buy
+6,560
New +$2.22M 0.78% 71

Other funds holding SNPS

Paradiem's SNPS Position: Q2 2025 in Review

Paradiem sold out of Synopsys (SNPS) in Q2 2025, closing a stake of 9,636 shares — an estimated $4.13M sold.

Paradiem first reported a position in SNPS in Q3 2022 and held it in 11 quarters. The position peaked at $5.47M in Q4 2024. 1,294 funds tracked by Wall St. Rank hold SNPS as of Q2 2025.

  • Paradiem reported no remaining Synopsys position as of Q2 2025 after selling out during the quarter.
  • Paradiem sold 9,636 Synopsys shares in Q2 2025, an estimated $4.13M.
  • Paradiem first reported a position in Synopsys in Q3 2022 and held it in 11 quarters.
  • Paradiem's Synopsys position peaked at $5.47M in Q4 2024.
  • 1,294 funds tracked by Wall St. Rank held Synopsys as of Q2 2025.

Based on Paradiem's 13F filing for Q2 2025, filed 17 Jul 2025.